← Leaderboards
Mark A Herman
Beth Israel Deaconess Medical Center
$6,685,137
Attributed
$8,353,821
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,550,688 · 7
By mechanism
R01$7,585,512 · 4
P30$1,315,986 · 2
K08$649,190 · 1
Top collaborators
- Christopher B Newgard4 shared
- Kristin Eckel Mahan1 shared
- Maria Jose Redondo1 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- David C Jimerson$1,447,324
- Fredric E. Wondisford$29,129,494
- Christiane Ferran$11,467,818
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectObesityMetabolicDiabetes MellitusBlood Glucose RegulationResponseInsulin ResistanceProgramsOverexpressionMetabolismPreventMetabolic DiseasesEnzymesGenesMolecularDietFructoseHomeostasisLiverMouse ModelGeneticHepaticCarbohydratesGlucose
Grant awards (23)
Houston Nutrition Obesity Research Center$1,196,867
P30 · FY2025 · DK · contact PI
ChREBP in Liver Metabolism: Defining Mechanisms and Resolving Controversies$626,429
R01 · FY2025 · DK · contact PI
Houston Nutrition Obesity Research Center Admin-Core$119,119
P30 · FY2025 · DK · contact PI
The Role of ChREBP in Fructose Induced Metabolic Disease$449,011
R01 · FY2023 · DK · contact PI
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$651,201
R01 · FY2022 · DK
The Role of ChREBP in Fructose Induced Metabolic Disease$451,818
R01 · FY2022 · DK · contact PI
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$659,801
R01 · FY2021 · DK
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES$651,363
R01 · FY2021 · DK · contact PI
The Role of ChREBP in Fructose Induced Metabolic Disease$451,818
R01 · FY2021 · DK · contact PI
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$666,411
R01 · FY2020 · DK
The Role of ChREBP in Fructose Induced Metabolic Disease$451,818
R01 · FY2020 · DK · contact PI
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$708,592
R01 · FY2019 · DK
The Role of ChREBP in Fructose Induced Metabolic Disease$345,825
R01 · FY2018 · DK · contact PI
The Role of ChREBP in Fructose Induced Metabolic Disease$345,825
R01 · FY2017 · DK · contact PI
The Role of ChREBP in Fructose Induced Metabolic Disease$265,350
R01 · FY2016 · DK · contact PI
The Role of ChREBP in Fructose Induced Metabolic Disease$103,350
R01 · FY2016 · DK · contact PI
The Role of ChREBP in Fructose Induced Metabolic Disease$378,450
R01 · FY2015 · DK · contact PI
The Role of ChREBP in Fructose Induced Metabolic Disease$378,450
R01 · FY2014 · DK · contact PI
Adipose Tissue Branched-Chain Amino Acid Metabolism and Glucose Homeostasis$129,870
K08 · FY2010 · DK · contact PI
Adipose Tissue Branched-Chain Amino Acid Metabolism and Glucose Homeostasis$129,870
K08 · FY2009 · DK · contact PI
Adipose Tissue Branched-Chain Amino Acid Metabolism and Glucose Homeostasis$129,870
K08 · FY2008 · DK · contact PI
Adipose Tissue Branched-Chain Amino Acid Metabolism and Glucose Homeostasis$129,870
K08 · FY2007 · DK · contact PI
Adipose Tissue Branched-Chain Amino Acid Metabolism and Glucose Homeostasis$129,710
K08 · FY2006 · DK · contact PI